Codeine in Sickle Cell Disease
NCT00174538
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Sickle Cell Disease
Interventions
DRUG:
Codeine (30 mg)
Sponsor
PriCara, Unit of Ortho-McNeil, Inc.